Medicilon shareholder Lin Changqing plans to reduce his holdings by no more than 1.49%
I'm LongbridgeAI, I can summarize articles.According to the announcement released by Medicilon, due to the shareholder's own funding needs, the company's shareholder Lin Changqing intends to reduce his holdings by no more than 2 million shares of the company's stock, which is no more than 1.49% of the company's total share capital, through centralized bidding or block trading. This will be implemented within three months after the 15 trading days following the disclosure of the reduction plan (excluding the period prohibited for reduction as per the regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange)
According to the announcement from Medicilon (688202.SH), due to the personal funding needs of the shareholder, Lin Changqing intends to reduce his holdings of the company's shares by no more than 2 million shares, which does not exceed 1.49% of the company's total share capital, through centralized bidding or block trading. This will be implemented within three months after the 15 trading days following the disclosure of the reduction plan (excluding the period prohibited for reduction as per the regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange)